• Collaboration

  • News

  •  Healthcare Professionals

  • Contact us




Pfizer's novel COVID-19 oral treatment arrives in New Zealand


Pfizer to Provide NZ with 60,000 Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19


Pfizer and BioNTech to Supply New Zealand with their Vaccine Against COVID-19

Media Enquiries

Accredited journalists can contact the Pfizer Australia & New Zealand Media Relations team at: mediaanz@pfizer.com.  

Please note that this email address is intended specifically for journalists with media enquiries and unfortunately, we are unable to respond to any non-media enquiries sent to this address. 

ABOUT US About Pfizer New Zealand Our history Manufacturing OUR SCIENCE Our focus areas Search for a Clinical Trial Clinical Research Centre for Therapeutic Innovation Pfizer Healthcare Hub Pfizer Medical Information OUR PRODUCTS Product finder Medical Information Contacts Patient Websites OUR PEOPLE Careers NZ Management team ANZ Leadership team Corporate Social Responsibility program Our values